Superworth

UnitedHealth UNH

Medical - Healthcare Plans, Healthcare
$399.19
−0.31%
Market cap
$358.3B
PE
22.8×
10y median 22.7×
Forward PE
17.6×
10y median 19.4×
Price to sales
0.8×
EV/EBIT
16.8×
Revenue, 12 months
$449.7B
+3% on a year ago
Net margin
3.5%
Free cash flow yield
n/m
Q3 FY26 missing

A Superworth story

UnitedHealth is shrinking to get its profit back, and the price already counts on it

Margins are mending under a returning boss, but sales have stalled and Washington sets the rates

  1. The price more than halved, then won back about half the fall

    From its November 2024 high to its August 2025 low, the stock lost about 62%, as new Medicare members cost more than planned and it pulled its forecast. Stephen Hemsley, who ran the company from 2006 to 2017, came back as chief executive to fix it. A second scare came in January 2026, when Washington proposed almost no raise in Medicare rates for 2027. The price is up about 60% from its March low.

  2. The engine that broke was the slice of each dollar it keeps

    For most of the last decade, UnitedHealth kept about 8 cents of operating profit from each dollar of revenue. Over four quarters to the end of 2025, that slice roughly halved. Repriced plans and dropped members have pulled it back to about 5 cents, the first real sign the fix is working.

  3. Sales stopped growing this year, on purpose

    UnitedHealth is walking away from members and markets that lose money. Its Medicare Advantage plans, the private version of Medicare that insurers run for the government, have about 935,000 fewer seniors than at the end of 2025. So four-quarter sales have gone flat since March, after years of growth near 10% a year.

  4. On reported profit it looks dear, and last winter's clean-up is why

    On reported profit the stock costs about 24 times the last four quarters, dearer than about two in three days of the last ten years. Most of that is one quarter: charges at the end of 2025 left reported earnings near zero. Adjusted earnings leave such items out, and on them it is about 20 times.

  5. The fear is that the rebound is borrowed

    Quarterly profit rose by about three quarters from a year earlier, but 610 million dollars of it came from bills for earlier periods landing below what was set aside. Washington sets Medicare Advantage rates each year. It first proposed almost no raise for 2027, then settled on about 2.5%. The 2028 proposal is due by early February.

  6. On expected earnings, it costs a little less than its habit

    At today's price, consensus adjusted earnings for the next twelve months put UnitedHealth at about 18 times, a little under its own ten-year median. Other big insurers trade nearer 13 times, so it still costs more than its rivals on the same measure. This history is rebuilt with today's estimates before late September.

  7. Analysts already count on the goal, so January has to beat it

    Analysts already pencil in about 14% higher adjusted earnings for 2027, inside the company's 13% to 16% long-term goal. The finance chief points to the low end, so an outlook there on January 20 only confirms what the price holds. One in the upper half, with costs in check, would be news. If costs or rates bite, the rebound was the easy part.

1 of 7

What has happened lately

Headlines link to the original source.

Brought to you by Superworth

Why a stock is priced where it is, one chart at a time.

Charts

Financials

Income statement for UNH, by quarter
Income statementQ4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
$94.4B+14%$99.8B+9%$98.9B+6%$100.8B+9%$100.8B+7%$109.6B+10%$111.6B+13%$113.2B+12%$113.2B+12%$111.7B+2%$112B+0%$112.7B−0%
Cost of revenue$10.2B+23%$11.1B+18%$11.3B+16%$11.8B+26%$12.5B+22%$12.4B+12%$13B+15%$12.6B+6%$12.7B+2%$12.8B+4%$13.4B+3%n/a
SG&A$13.3B+3%$14.1B+3%$13.2B−5%$13.3B−4%$12.5B−6%$13.6B−3%$13.8B+5%$15.2B+15%$17B+36%$15.4B+13%$14.3B+4%$14.4B−6%
$7.7B+12%$7.9B−2%$7.9B−2%$8.7B+2%$7.8B+1%$9.1B+15%$5.2B−35%$4.3B−50%$380M−95%$9B−1%$8B+55%$6.6B+52%
Interest expense$830M+23%$844M+12%$985M+19%$1.1B+29%$1B+21%$998M+18%$1B+4%$1B−7%$974M−3%$955M−4%$962M−6%n/a
Pre-tax income$6.9B+10%$1M−100%$5.7B−22%$7.6B−1%$6.8B−1%$8.1B+810500%$4.1B−28%$3.2B−58%−$720M$8B−2%$7B+71%$5.5B+71%
$1.2B−9%$1.2B−22%$1.2B−21%$1.4B−18%$1B−15%$1.6B+34%$510M−59%$686M−49%−$938M$1.5B−9%$1.3B+155%$1.2B+78%
Net income$5.5B+15%−$1.4B$4.2B−23%$6.1B+4%$5.5B+2%$6.3B$3.4B−19%$2.3B−61%$10M−100%$6.3B−0%$5.5B+61%$4.1B+75%
$5.83+16%−$1.53$4.54−22%$6.51+4%$5.98+3%$6.85$3.74−18%$2.59−60%$0.01−100%$6.90+1%$6.04+62%$4.56+76%
935M−1%922M−2%928M−1%930M−1%927M−1%918M−0%910M−2%908M−2%910M−2%910M−1%906M−0%n/a

Net income: 12 periods, Q4 FY09 to Q4 FY25: printed in the fourth-quarter results release.

EPS, diluted: Q4 FY08 and Q4 FY16: quarter's net income to common over its shares, to the cent. 12 periods, Q4 FY09 to Q4 FY25: printed in the fourth-quarter results release.

Diluted shares: 6 periods, Q4 FY08 to Q4 FY16: share-days: the 12-month average less the 9-month, weighted by days. 12 periods, Q4 FY09 to Q4 FY25: printed in the fourth-quarter results release.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet. Figures from older filings without data tags, and from a results release before its 10-Q, are read from the document's text and checked against it.

Estimates

Next earnings report: .

QuarterRevenueRangeEPSRangeAnalysts
Q4 FY26$112.3B$109.7B to $115.1B$2.28$2.19 to $2.5416
Q1 FY27$113.5B$110.6B to $116.4B$8.14$6.67 to $8.7612
Q2 FY27$115.3B$112B to $118.5B$6.92$6.66 to $7.175
Q3 FY27$116.5B$113.2B to $119.7B$5.32$5.12 to $5.515
Q4 FY27$117.6B$114.3B to $120.9B$3.07$2.96 to $3.185
Q1 FY28$120.2B$116.8B to $123.5B$9.13$8.79 to $9.466
Q2 FY28$122.2B$118.8B to $125.6B$7.95$7.66 to $8.246
Q3 FY28$123B$119.5B to $126.4B$6.51$6.27 to $6.746

Peers

Companies in Medical - Healthcare Plans nearest UnitedHealth's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
UNHUnitedHealth$356.9B22.7×22.7×17.6×0.8×+3%3.5%
CVSCVS Health$113.7B23.5×16.2×10.9×0.3×+7%1.2%
ELVElevance Health$89.7B18.4×17.7×15.1×0.4×+6%2.5%
CICigna$77.8B12.2×16.1×9.3×0.3×+8%2.3%
HUMHumana$49.5B39.0×20.7×33.0×0.3×+18%0.9%
Peer median$83.8B20.9×16.9×13.0×0.3×+8%1.7%

Investors who own it

Investors we follow who held UnitedHealth at the end of Jun 30, 2026, from their 13F filings.

More on UnitedHealth

Each number over time

Where it ranks

Its groups

About

Chief executive
Stephen Hemsley, since 2025Returned as CEO in May 2025 after leading from 2006 to 2017. Source
Industry
Medical - Healthcare Plans
Sector
Healthcare

Valuation data, not investment advice. Prices as of .